Compare XLO & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XLO | VTSI |
|---|---|---|
| Founded | 2016 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 51.0M |
| IPO Year | 2021 | 1999 |
| Metric | XLO | VTSI |
|---|---|---|
| Price | $9.01 | $3.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $5.00 |
| AVG Volume (30 Days) | 27.3K | ★ 52.3K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,766,000.00 | $185,971.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $168.77 | $27.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 589.88 | N/A |
| 52 Week Low | $0.46 | $3.16 |
| 52 Week High | $9.30 | $7.47 |
| Indicator | XLO | VTSI |
|---|---|---|
| Relative Strength Index (RSI) | 65.15 | 32.67 |
| Support Level | $7.47 | N/A |
| Resistance Level | $8.97 | $3.60 |
| Average True Range (ATR) | 0.50 | 0.16 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 81.49 | 3.48 |
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.